Immunohistochemical characterization of neoplastic cells of breast origin

Diagnostic Pathology

Volumn 7, Issue 1, 2012, Pages

  Noriega, MariadelasMercedes ^a   Paesani, Fernando ^a   Perazzo, Florencia ^a   Lago, Néstor ^b   Krupitzki, Hugo ^a   Nieto, Silvana ^a   Garcia, Alejandro ^a   Avagnina, Alejandra ^a   Elsner, Boris ^a   Denninghoff, Valeria C ^a  

^a CEMIC   (Argentina)

^b CEMIC ^*  (Argentina)

Author keywords

Breast; Immunohistochemistry; Mammaglobin; Tumors of unknown origin

Indexed keywords

CARRIER PROTEIN; CYTOKERATIN 7; ESTROGEN RECEPTOR; GLYCOPROTEIN; KRT7 PROTEIN, HUMAN; PIP PROTEIN, HUMAN; PROGESTERONE RECEPTOR; SECRETOGLOBIN; TUMOR MARKER;

ARTICLE; BIOPSY; BREAST TUMOR; CANCER OF UNKNOWN PRIMARY SITE; CHEMISTRY; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; PATHOLOGY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY;

BIOPSY; BREAST NEOPLASMS; CARRIER PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-7; NEOPLASMS, UNKNOWN PRIMARY; PREDICTIVE VALUE OF TESTS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SECRETOGLOBINS; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862508275     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-7-73     Document Type: Article

References (23)

1. Breast Cancer: Prevention and Control. World Health Organization http://www.who.int/cancer/detection/breastcancer/en/index1.html.
2. Hainsworth JD, Greco FA. Management of patients with cancer of unknown primary site. Oncology 2000, 14:563-579.
3. Krementz ET, Cerise EJ, Foster DS, Morgan LR. Metastases of undetermined source. Curr Probl Cancer 1979, 4:4-37.
4. Briasoulis E, Pavlidis N. Cancer of unknown Primary Origin. The Oncologist 1997, 2:142-152.
5. ESMO Guidelines Task Force ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of cancers of unknown primary site. Ann Oncol 2001, 12:1057-1058. ESMO Guidelines Task Force.
6. Gillanders WE, Mikhitarian K, Hebert R, Mauldin PD, Palesch Y, Walters C, Urist MM, Mann GB, Doherty G, Herrmann VM, Hill AD, Eremin O, El-Sheemy M, Orr RK, Valle AA, Henderson MA, Dewitty RL, Sugg SL, Frykberg E, Yeh K, Bell RM, Metcalf JS, Elliott BM, Brothers T, Robison J, Mitas M, Cole DJ. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes. Ann Surg 2004, 239:828-840. 10.1097/01.sla.0000128687.59439.d6, 1356291, 15166962.
7. Allende D, Denninghoff V, Avagnina A, Elsner B. Sentinel lymph nodes study: how to do it right? The Argentinean experience. Breast J 2008, 14:216-217. 10.1111/j.1524-4741.2007.00564.x, 18248555.
8. Révillion F, Lhotellier V, Hornez L, Leroy A, Baranzelli MC, Giard S, Boneterre J, Pevrat JP. Real-time reverse-transcription PCR to quantify a panel of 19 genes in breast cancer: relationships with sentinel lymph node invasion. Int J Biol Markers 2008, 23:10-17.
9. Fleming TP, Watson MA. Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer. Ann N Y Acad Sci 2000, 923:78-89.
10. Fritzsche FR, Thomas A, Winzer KJ, Beyer B, Dankof A, Bellach J, Dahl E, Dietel M, Kristiansen G. Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer. Histol Histopathol 2007, 22:1221-1230.
11. Chia SY, Thike AA, Cheok PY, Tan PH. Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors. Breast 2010, 19:355-359. 10.1016/j.breast.2010.02.007, 20347310.
12. Takeda Y, Tsuta K, Shibuki Y, Hoshino T, Tochigi N, Maeshima AM, Asamura H, Sasajima Y, Ito T, Matsuno Y. Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. Arch Pathol Lab Med 2008, 132:239-243.
13. Bhargava R, Beriwal S, Dabbs DJ. Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity. Am J Clin Pathol 2007, 127:103-113. 10.1309/TDP92PQLDE2HLEET, 17145637.
14. Liberman L. Pathologic analysis of sentinel lymph nodes in breast carcinoma. Cancer 2000, 88:971-977. 10.1002/(SICI)1097-0142(20000301)88:5<971::AID-CNCR3>3.0.CO;2-F, 10699882.
15. Sasaki E, Tsunoda N, Hatanaka Y, Mori N, Iwata H, Yatabe Y. Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers. Mod Pathol 2007, 20:208-214. 10.1038/modpathol.3800731, 17192791.
16. Dennis JL, Hvidsten RT, Wit EC, Komorowski J, Bell AK, Downie I, Mooney J, Verbeke C, Bellamy C, Keith WN, Oien KA. Markers of Adenocarcinoma Characteristic of the Site of Origin: Development of a Diagnostic Algorithm. Clin Cancer Res 2005, 11:3766-3772. 10.1158/1078-0432.CCR-04-2236, 15897574.
17. Aihara T, Fujiwara Y, Miyake Y, Okami J, Okada Y, Iwao K, Sugita Y, Tomita N, Sakon M, Shiozaki H, Monden M. Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers. Cancer Lett 2000, 150:79-84. 10.1016/S0304-3835(99)00378-X, 10755390.
18. Watson MA, Darrow C, Zimonjic DB, Popescu NC, Fleming TP. Structure and Transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to Chromosome 11q13. Oncogene 1998, 16:817-824. 10.1038/sj.onc.1201597, 9488047.
19. Kazuya O, Dabbs DJ, Bhargava R. Mammaglobin Expression in the female genital tract: Immunohistochemical Analysis in Benign and Neoplastic Endocervix and Endometrium. Inter J Gynecol Pathol 2008, 27:1418-1425.
20. Han JH, Kang Y, Shin HC, Kim HS, Kang YM, Kim YB, Oh SY. Mammaglobin expression in lymph nodes is an important marker of metastatic breast carcinoma. Arch Pathol Lab Med 2003, 127:1330-1334.
21. Yang M, Nonaka D. A study of immunohistochemical differential expression in pulmonary and mammary carcinomas. Mod Pathol 2010, 23:654-661. 10.1038/modpathol.2010.38, 20173733.
22. Laurinaviciene A, Dasevicius D, Ostapenko V, Jarmalaite S, Lazutka J, Laurinavicius A. Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays. Diagn Pathol 2011, 6:87-96. 10.1186/1746-1596-6-87, 3191356, 21943197.
23. Laurinavicius A, Laurinaviciene A, Ostapenko V, Dasevicius D, Jarmalaite S, Lazutka J. Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data. Diagn Pathol 2012, 7:27-42. 10.1186/1746-1596-7-27, 3319425, 22424533.